The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
Open accessAbstract
BACKGROUND: Patients with cystic fibrosis are known to have decreased mucociliary clearance. It has previously been shown that inhalation of a 7.0% solution of hypertonic saline significantly improved mucociliary clearance in a group of adult patients with cystic fibrosis. The aim of this study was to measure the response to increasing concentrations of inhaled hypertonic saline. METHODS: Ten patients (seven men) of mean (SE) age 22 (4) years and mean forced expiratory volume in one second (FEV1) 52.0 (6.7)% predicted completed the study. Mucociliary clearance was measured using a radioaerosol technique for 90 minutes after the interventions which comprised 0.9% NaCl + voluntary cough (control), 3.0% NaCl, 7.0% NaCl, and 12% NaCl. RESULTS: There was a significant increase in the amount of activity cleared from the right lung with all concentrations of hypertonic saline (HS) compared with control. The amount cleared at 90 minutes on the control day was 12.7% (95% confidence interval (CI) 9.8 to 17.2) compared with 19.7% (95% CI 13.6 to 29.5) for 3% HS, 23.8% (95% CI 15.9 to 36.7) for 7% HS and 26.0% (95% CI 19.8 to 35.9) for 12% HS. The improvement in mucociliary clearance was not solely due to coughing as the number of coughs recorded on the control day exceeded that recorded on any other day. The hypertonic saline did not induce a clinically significant change in FEV1. CONCLUSIONS: Within the range of concentrations examined in this study, the effect of hypertonic saline appears to be dose dependent. Inhalation of hypertonic saline remains a potentially useful treatment for patients with cystic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Practical Statistics for Medical Research
Newcombe, R. G. (1992) · Journal of Epidemiology and Community Health · doi:10.1136/jech.46.5.549-a · Cited by 981
Robinson, M., Regnis, J. A., Bailey, D. L., King, M., Bautovich, G. J., & Bye, P. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630593 · Cited by 232
Self-citationElemental Composition of Human Airway Surface Fluid in Healthy and Diseased Airways
Joris, L., Dab, I., & Quinton, P. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.6_pt_1.1633 · Cited by 210
Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis
Eng, P. A., Morton, J., Douglass, J. A., Riedler, J., Wilson, J., & Robertson, C. F. (1996) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199602)21:2<77::aid-ppul3>3.0.co;2-m · Cited by 194
Mucociliary clearance in patients with cystic fibrosis and in normal subjects.
Regnis, J. A., Robinson, M., Bailey, D. L., Cook, P., Hooper, P., Chan, H. K., Gonda, I., Bautovich, G., & Bye, P. T. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.8025774 · Cited by 180
Self-citationDaviskas, E., Anderson, S., Gonda, I., Eberl, S., Meikle, S., Seale, J., & Bautovich, G. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040725 · Cited by 178
Self-citation
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., Belousova, E. G., Xuan, W., & Bye, P. T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043900 · Cited by 862
Self-citationMucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043891 · Cited by 694
New concepts of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00057003 · Cited by 640
Metadata
- Authors
- Robinson, M., Hemming, A. L., Regnis, J. A., Wong, A. G., Bailey, D. L., Bautovich, G. J., King, M., & Bye, P. T.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1997-10
- Volume
- 52
- Issue
- 10
- Pages
- 900-903
- ISSN
- 0040-6376 (ISSN-L)
- 1468-3296
- OpenAlex
- W2168454304
- Cited by
- 265
- References
- 14
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. https://app.cochat.ai/papers/10.1136/thx.52.10.900
- The paper
- Robinson, M., Hemming, A. L., Regnis, J. A., Wong, A. G., Bailey, D. L., Bautovich, G. J., King, M., & Bye, P. T. (1997). Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax. https://doi.org/10.1136/thx.52.10.900
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.